Comparative Accuracy Analysis of a Real-time and an Intermittent-Scanning Continuous Glucose Monitoring System
- 17 December 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 15 (2) , 287-293
Abstract
Background: Currently, two different types of continuous glucose monitoring (CGM) systems are available: real time (rt) CGM systems that continuously provide glucose values and intermittent-scanning (is) CGM systems. This study compared accuracy of an rtCGM and an isCGM system when worn in parallel. Methods: Dexcom G5 Mobile (DG5) and FreeStyle Libre (FL) were worn in parallel by 27 subjects for 14 days including two clinic sessions with induced glucose excursions. The percentage of CGM values within ±20% or ±20 mg/dL of the laboratory comparison method results (YSI 2300 STAT Plus, YSI Inc., Yellow Springs, OH, United States; glucose oxidase based) or blood glucose meter values and mean absolute relative difference (MARD) were calculated. Consensus error grid and continuous glucose error grid analyses were performed to assess clinical accuracy. Results: Both systems displayed clinically accurate readings. Compared to laboratory comparison method results during clinic sessions, DG5 had 91.5% of values within ±20%/20 mg/dL and a MARD of 9.5%; FL had 82.5% of scanned values within ±20%/20 mg/dL and an MARD of 13.6%. Both systems showed a lower level of performance during the home phase and when using the blood glucose meter as reference. Conclusion: The two systems tested in this study represent two different principles of CGM. DG5 generally provided higher accordance with laboratory comparison method results than FL.Keywords
Funding Information
- DexCom Inc.
This publication has 14 references indexed in Scilit:
- Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose MonitoringParts of the data have previously been presented at the 77th Scientific Sessions of the American Diabetes Association in San Diego, CA; June 9–13, 2017 and at the 17th Annual Diabetes Technology Meeting in Bethesda, MD, November 2–4, 2017.Trial number: DRKS00011920; registered at the Deutsches Register Klinischer Studien (German clinical trials register), an approved Primary Register in the WHO International Clinical Trials Registry Platform.Diabetes Technology & Therapeutics, 2018
- Venous, Arterialized-Venous, or Capillary Glucose Reference Measurements for the Accuracy Assessment of a Continuous Glucose Monitoring SystemDiabetes Technology & Therapeutics, 2017
- Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and GluteusJournal of Diabetes Science and Technology, 2017
- Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Is It Safe?Journal of Diabetes Science and Technology, 2017
- Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitusBMJ Open Diabetes Research & Care, 2017
- FDA Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGMDiabetes Technology & Therapeutics, 2016
- The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring SystemDiabetes Technology & Therapeutics, 2015
- Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose MonitoringDiabetes Technology & Therapeutics, 2015
- Clinical Accuracy of a Continuous Glucose Monitoring System With an Advanced AlgorithmJournal of Diabetes Science and Technology, 2014
- Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemiaDiabetologia, 1992